Literature DB >> 25476585

Personalized therapies in psychiatry: promises, pitfalls and perspectives.

Katharina Domschke1, Daniel J Müller, Alessandro Serretti.   

Abstract

Mesh：

Year:  2015        PMID： 25476585     DOI： 10.1007/s00702-014-1340-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


× No keyword cloud information.
  10 in total

1.  Ethical problems in pharmacogenetic studies of psychiatric disorders.

Authors:  A Serretti; P Artioli
Journal:  Pharmacogenomics J       Date:  2006-03-21       Impact factor: 3.550

Review 2.  Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic.

Authors:  Daniel J Müller; Ivana Kekin; Amy C C Kao; Eva J Brandl
Journal:  Int Rev Psychiatry       Date:  2013-10

Review 3.  Making sense of deep sequencing.

Authors:  D Goldman; K Domschke
Journal:  Int J Neuropsychopharmacol       Date:  2014-06-13       Impact factor: 5.176

4.  The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction.

Authors:  Sidney H Kennedy; Jonathan Downar; Kenneth R Evans; Harriet Feilotter; Raymond W Lam; Glenda M MacQueen; Roumen Milev; Sagar V Parikh; Susan Rotzinger; Claudio Soares
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Challenging sequential approach to treatment resistant depression: cost-utility analysis based on the Sequenced Treatment Alternatives to Relieve Depression (STAR(⁎)D) trial.

Authors:  Paolo Olgiati; Emanuele Bajo; Marco Bigelli; Stuart Montgomery; Alessandro Serretti
Journal:  Eur Neuropsychopharmacol       Date:  2013-09-13       Impact factor: 4.600

Review 6.  Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.

Authors:  Katarzyna Drozda; Daniel J Müller; Jeffrey R Bishop
Journal:  Pharmacotherapy       Date:  2014-02       Impact factor: 4.705

Review 7.  Imaging genetics of anxiety disorders.

Authors:  Katharina Domschke; Udo Dannlowski
Journal:  Neuroimage       Date:  2009-11-26       Impact factor: 6.556

Review 8.  The intersection of pharmacology, imaging, and genetics in the development of personalized medicine.

Authors:  Philip Gerretsen; Daniel J Müller; Arun Tiwari; David Mamo; Bruce G Pollock
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

Review 9.  Epigenetic alterations in depression and antidepressant treatment.

Authors:  Andreas Menke; Elisabeth B Binder
Journal:  Dialogues Clin Neurosci       Date:  2014-09       Impact factor: 5.986

10.  Personalized medicine: some thoughts.

Authors:  Werner Kalow
Journal:  Mcgill J Med       Date:  2007-01
  10 in total
  4 in total

1.  Covariation bias in depression - a predictor of treatment response?

Authors:  Saskia Stonawski; Julian Wiemer; Catherina Wurst; Jannika Reitz; Leif Hommers; Andreas Menke; Katharina Domschke; Miriam A Schiele; Paul Pauli
Journal:  J Neural Transm (Vienna)       Date:  2019-10-19       Impact factor: 3.575

Review 2.  Personalized medicine beyond genomics: alternative futures in big data-proteomics, environtome and the social proteome.

Authors:  Vural Özdemir; Edward S Dove; Ulvi K Gürsoy; Semra Şardaş; Arif Yıldırım; Şenay Görücü Yılmaz; I Ömer Barlas; Kıvanç Güngör; Alper Mete; Sanjeeva Srivastava
Journal:  J Neural Transm (Vienna)       Date:  2015-12-08       Impact factor: 3.575

3.  Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes.

Authors:  Michael G Gottschalk; Jan Richter; Christiane Ziegler; Miriam A Schiele; Julia Mann; Maximilian J Geiger; Christoph Schartner; György A Homola; Georg W Alpers; Christian Büchel; Lydia Fehm; Thomas Fydrich; Alexander L Gerlach; Andrew T Gloster; Sylvia Helbig-Lang; Raffael Kalisch; Tilo Kircher; Thomas Lang; Tina B Lonsdorf; Christiane A Pané-Farré; Andreas Ströhle; Heike Weber; Peter Zwanzger; Volker Arolt; Marcel Romanos; Hans-Ulrich Wittchen; Alfons Hamm; Paul Pauli; Andreas Reif; Jürgen Deckert; Susanne Neufang; Michael Höfler; Katharina Domschke
Journal:  Transl Psychiatry       Date:  2019-02-04       Impact factor: 6.222

4.  Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed With Bipolar Disorder.

Authors:  Santiago Sánchez-Iglesias; Virginia García-Solaesa; Belén García-Berrocal; Almudena Sanchez-Martín; Carolina Lorenzo-Romo; Tomás Martín-Pinto; Andrea Gaedigk; José Manuel González-Buitrago; María Isidoro-García
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.